Tonix Pharmaceuticals announced it will release its third quarter 2026 financial results on November 9, 2026, with a conference call and webcast. The company, focused on central nervous system disorders, infectious diseases, and immunology, markets products like TONMYA® for fibromyalgia and migraine treatments. Tonix is also advancing clinical trials for new indications and vaccines, including Lyme disease and mpox prevention. This update will provide investors insight into the company's commercial progress and pipeline developments.
Tonix Pharmaceuticals' upcoming Q3 2026 financial results announcement provides context for readers. For those following the health sector, here is Pluang's market snapshot as of Oct 26, 2026 18:11 WIB: Out of 150 priced US health stocks, 82 rose and 35 fell. Notable prices include Adaptive Biotechnologies Corp at USD 25.07 with a 1-day change of -1.72% and a typical hold time of 37 days, Immunovant Inc. at USD 28.03 down 1.34% with a 17-day hold, and Johnson & Johnson at USD 266.99 up 1.21% with a 130-day hold time.
Smithfield Foods has created a $250,000 Future Leaders Scholarship program at Christopher Newport University to support eight incoming business students with $7,500 annual scholarships renewable for up to four years. The program aims to help local st...
E-Power Inc.'s joint venture, Sunrise Guizhou, received RMB 110 million of a planned RMB 200 million capital increase, raising its registered capital and valuing the company at RMB 2 billion post-money. The funds will support business expansion, R&D,...
AS Tallinna Sadam has signed a €50 million unsecured loan agreement with Swedbank, with a 5-year term and interest based on 3-month Euribor plus a margin. The loan will be fully drawn on October 26, 2026, and matures on October 26, 2031. This financi...
AS Tallinna Sadam signed a €50 million unsecured loan agreement with AS Swedbank, maturing in five years with an interest rate based on 3-month Euribor plus margin. The loan, drawn on October 26, 2026, will be used to redeem bonds worth €50.4 million...
Vita Coco, a leading coconut water brand, has partnered with Homesick to create a limited-edition candle collection inspired by Vita Coco Treats flavors: Strawberries & Creme and Frosted Lemonade. The candles capture the essence of these flavors thro...
